NYSE · Medical - Diagnostics & Research

IQVIA Holdings, Inc. (IQV) Stock

$259.88 +0.39% NYSE: IQV Healthcare

Valuation

MetricValue
Price$259.88
Market Cap$42.78B
P/E Ratio31.76
P/B Ratio7.00
P/S Ratio2.50
EPS (TTM)$8.06
52-Week High$277.40
52-Week Low$154.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE21.95%
ROA4.60%
ROCE10.94%
Gross Margin14.02%
Operating Margin14.02%
Net Margin8.10%
Debt/Equity2.63
Current Ratio0.75

Annual Financials (USD)

Metric20212022202320242025
Revenue$13.9B$14.4B$15.0B$15.4B$16.3B
Operating Profit$1.4B$1.8B$2.0B$2.2B$2.3B
Net Profit$966.0M$1.1B$1.4B$1.4B$1.4B
EPS$4.95$5.72$7.29$7.49$7.84
Op Margin10.0%12.5%13.2%14.3%14.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$24.7B$25.3B$26.7B$26.9B$29.9B
Total Liabilities$18.6B$19.6B$20.6B$20.8B$23.3B
Cash$1.4B$1.2B$1.4B$1.7B$2.0B
Borrowings$12.4B$13.0B$13.9B$14.2B$16.2B

Latest News

IQV vs. PEN: Which Stock Is the Better Value Option? Zacks · Jul 14, 2026 Baird Adjusts IQVIA Price Target to $252 From $249, Maintains Outperform Rating MT Newswires · Jul 13, 2026 Mizuho Adjusts Price Target on IQVIA Holdings to $230 From $215, Maintains Outperform Rating MT Newswires · Jul 13, 2026 1 Cash-Producing Stock to Target This Week and 2 We Question StockStory · Jul 10, 2026 IQVIA (IQV) Just Drew A New Artisan Partners Bet On AI And Resilience Simply Wall St. · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$2.9B$2.3B$2.1B$2.7B$2.7B
Investing Cash Flow$-2.7B$-2.7B$-2.3B$-2.0B$-2.9B
Financing Cash Flow$-1.3B$-1.3B$-1.2B$-1.4B$-1.3B
Net Cash Flow$-448.0M$-150.0M$160.0M$326.0M$278.0M
Free Cash Flow$2.3B$1.6B$1.5B$2.1B$2.1B

Valuation & Return Ratios

MetricValue
PEG Ratio1.93
EV / EBITDA16.11
FCF Yield6.15%
Quick Ratio0.71
Interest Coverage2.99
Return 1Y29.05%
Return 3Y29.74%
Return 5Y11.15%

Ownership

Insiders Held1.08%
Institutions Held104.08%
Institutions Float Held105.22%
Institutional HolderSharesReport Date
Blackrock Inc.15,027,4442026-03-31
Harris Associates L.P.12,183,2752026-03-31
Vanguard Capital Management LLC11,026,9832026-03-31
Vanguard Portfolio Management LLC7,576,0012026-03-31
State Street Corporation7,476,9622026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALBBYAlibaba Health Information Technology Limited $8.60 -7.63% 24.56 $6.93B 0.00%
CERTCertara, Inc. $9.13 +5.67% -21.11 $1.42B 0.00%
CRLCharles River Laboratories International, Inc. $301.79 +1.27% -59.96 $14.54B 0.00%
FTREFortrea Holdings Inc. $20.84 +2.31% -21.51 $1.98B 0.00%
HCATHealth Catalyst, Inc $1.77 +1.14% -0.48 $130.79M 0.00%

About IQVIA Holdings, Inc.

IQVIA Holdings, Inc. is led by CEO Ari Bousbib, employs 89,000 people, headquartered in Durham, US, publicly traded since 2013.

IQVIA Holdings, Inc. (IQV) stock trades at $259.88 with a market capitalization of $42.78B. The stock is valued at a price-to-earnings (P/E) ratio of 31.76, price-to-book of 7.00, price-to-sales of 2.50. Over the past 52 weeks the stock has ranged between $154.50 and $277.40, and currently trades 6.3% below its 52-week high.

On profitability, IQVIA Holdings, Inc. generates a return on equity (ROE) of 21.95% — well above the market average, a sign of a high-quality business, return on capital employed of 10.94%, an operating margin of 14.02%, a net profit margin of 8.10%.

In its most recent fiscal year, IQVIA Holdings, Inc. reported annual revenue of $16.3B, net profit of $1.4B, revenue has compounded at 7.5% a year over the last five years, profit at 37.3% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 2.63 — a leveraged balance sheet worth monitoring, a current ratio of 0.75, total assets of $29.9B, $2.0B in cash and equivalents.

IQV has a beta of 1.19.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides